Mammoth Biosciences
Mandy W. has extensive work experience in finance and accounting roles. Mandy currently serves as the VP, Corporate Controller at Mammoth Biosciences, a research and development company dedicated to CRISPR technology. Prior to this, they held positions at Vaxcyte, serving as the Sr. Director, Controller. Mandy also worked at Vaxcyte (formerly SutroVax) as a Controller. Mandy has experience as a Finance and Accounting Consultant at DLC and as a Corporate Controller at Axiom Global, a global legal services provider. Mandy also worked as a Controller, Financial Reporting at URS Corporation, a Fortune 500 global provider of engineering services. Mandy started their career as an Accounting Supervisor at Charles Schwab Corporation.
Mandy W. has a Bachelor's degree in Accounting from San Francisco State University. Mandy also holds a High School Degree from Lowell High School. Additionally, they have certifications as a Certified Public Accountant from the California Board of Accountancy and as a Microsoft Excel 2013 Expert from Microsoft.
This person is not in the org chart
Mammoth Biosciences
3 followers
Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to improve lives by reading and writing the code of life. Mammoth aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, Cas14, and CasΦ, Mammoth can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.